Kroger Establishes Clinical Trial Site Network to Increase Access and Access to Health Research Studies

Announcement comes in collaboration with biopharmaceutical industry to launch colorectal cancer clinical trial

Cincinnati, January 24, 2023 /PRNewswire/ — Kroger Health, The Kroger Co. (NYSE: KR), today announced the establishment of its Clinical Trials Site Network in conjunction with pharmaceutical industry sponsors, contract research organizations and health systems. The announcement comes with Kroger’s first trial in active recruitment for the Colorectal Cancer Gut and Immune Health Observation.

In collaboration with Persephone Biosciences, Kroger Health is actively recruiting for the ARGONAUT clinical study (NCT04638751) to identify microbiome-based biomarkers of colorectal cancer. beginning in Toledo, Ohio Select areas, Kroger Pharmacies and its affiliate, The Little Clinic LLC, will enroll an initial group of 55 people with a variety of colorectal cancer risk levels to advance the understanding of gut and immune health. Over the next year, Kroger Health plans to enroll additional participants and increase its locations.

“With our team of more than 24,000 health professionals, under the America’s Grocery umbrella, we are positioned at the nexus of food and health care, which gives us a unique opportunity to expand access to clinical trial opportunities,” Told Colleen Lindholz, Kroger Health president. “As a trusted community healthcare destination, we envision a future where our work transforms the clinical trial landscape and provides expanded testing access to the people we serve.”

A cancer that affects both men and women, colorectal cancer is a leading cancer killer in the U.S., according to the CDC.1, It has been proven that colorectal cancer screening saves lives. About nine out of 10 people whose colorectal cancer is detected early and treated appropriately are still alive after five years2,

Kroger Health is seeking participants with the following risk factors:

  • age 45 and older who need a colonoscopy as their standard of care
  • Age 18 or older with one or more first-degree relatives with a history of colorectal cancer
  • People who have found three or more polyps during colonoscopy or who have a personal history of colorectal cancer

A growing body of evidence suggests that the bacteria that live in the gut may affect a person’s risk for developing colorectal cancer. Data collected from this trial will be used to develop personalized medicines and find cancer-specific indicators that could help guide future treatment and preventive strategies, such as using food as medicine.

Ninety percent of the US population lives within five miles of a pharmacy3, and fifty-one percent of all Kroger stores are located in socially disadvantaged areas. With select Kroger pharmacies and Little Clinics now serving as clinical trial sites, America’s grocer is expanding its commitment to healthcare by creating research opportunities in the communities where customers live, work and eat Huh. Combined with Grocer’s data analytic capabilities, Kroger Health has been able to engage a wide range of populations in clinical trials. Digital tools, virtual care visits and in-person communication will help with patient retention throughout the study lifecycle. In addition, its clinics, dietitians, pharmacy services and relationships with other health care organizations enable Kroger Health to offer end-to-end clinical trial management in a variety of preventive and curative areas.

“Through our collaboration with health systems across the country, we can work to optimize the patient experience to improve health care delivery and maintain continuity of care while expanding the boundaries of care and treatment ” jim kirby, PharmD, chief commercial officer of Kroger Health. “This is the first of many clinical trial opportunities that we will be using as an alternative to the traditional clinical trial and research organization model.”

Those interested in participating in the Argonaut Study may call 1.833.317.0661 for more information on eligibility and study background.

about kroger
The Kroger Co. (NYSE: KR), we are dedicated to our mission: Feeding the Human Soul™. We are nearly half a million associates in our family of companies that serve more than 11 million customers daily through a seamless digital shopping experience and retail food stores under a variety of banner names, serving America through food inspiration and upliftment. serve, and build #ZeroHungerZeroWaste communities. By 2025. To learn more about us, visit our newsroom and Investor Relations site.

About Kroger Health:
Kroger Health, the healthcare division of The Kroger Company, is one of America’s leading retail healthcare organizations. Kroger Health and the Kroger Family of Pharmacies and Clinics operate more than 2,200 pharmacies and 226 clinics in 35 states, serving more than 17 million customers annually. Our team of 24,000 health practitioners, including pharmacists, nurse practitioners, dietitians and technicians, believe in practicing at the top of our license, enabling “food as medicine” to help prevent disease before it starts , and help people live a healthy life. Visit www.kroger.com/health for more information.

About Argonaut:
The official title of the ARGONAUT study is: “Development and analysis of a blood and stool sample bank for cancer patients, enabling systematic study of the impact of the blood and gut microbiome on response to treatment.” More information can be found at https://www.clinicaltrials.gov/ using the identifier NCT04638751.

  1. Centers for Disease Control and Prevention, Colorectal Cancer Statistics, Colorectal Cancer Statistics | CDC Colorectal Cancer Statistics | CDC
  2. Centers for Disease Control and Prevention, Basic Information About Colorectal Cancer | CDC Basic Information About Colorectal Cancer | CDC
  3. Strand MA, Bratberg J, Eukel H, Hardy M, Williams C. Community Pharmacists Contribution to Disease Management during the COVID-19 Pandemic. [Erratum appears in Prev Chronic Dis 2020;17. http://www.cdc.gov/pcd/issues/2020/20_0317e.htm.] Prev Chronic Dis 2020;17:200317. DOI: http://dx.doi.org/10.5888/pcd17.200317external icon

SOURCE Kroger Company

,

Leave a Comment